科学研究表明,NAD+是维持细胞健康不可或缺的分子,可以促进DNA修复...查看全文
cokiest2021-04-08 23:52
$ChromaDex(CDXC)$ WHY BOOSTING OUR NAD+ METABOLISM IS A KEY COMPONENT TO HEALTHY AGING
网页链接查看全文
xddx-顺势而为2021-03-13 19:08
三月读书:《基础生命科学》读书笔记—20210313
1、本书是有关生命科学的国内经典的教材,为以后可以顺利研究生命科学相关公司打下基础,本书可作为生命科学、基因工程等方面的工具书。
2、生物的化学组成:生物由细胞组成,组成细胞的元素中CHON占比96%。生物体主要由蛋白质、核酸、脂类...查看全文
智通财经APP获悉,近日,由于发展速度超预期,NMN(β-烟酰胺单核苷酸)长寿药概念股颇受市场追捧。A股方面,周一收盘,尔康制药(300267.SZ)20%涨停,众生药业(002317.SZ)、康惠制药(603139.SH)、西王食品(000639.SZ)涨停,其他相关概念股... 网页链接
$ChromaDex(CDXC)$ DEF 14A Other definitive proxy statements Accession Number: 0001628280-24-018138 Act: 34 Size: 2 MB 网页链接
$ChromaDex(CDXC)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001628280-24-018142 Act: 34 Size: 496 KB 网页链接
$ChromaDex(CDXC)$ ARS Annual Report to Security Holders Accession Number: 0001628280-24-018148 Act: 34 Size: 16 MB 网页链接
$ChromaDex(CDXC)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001628280-24-009380 Act: 34 Size: 9 MB 网页链接
$ChromaDex(CDXC)$ 8-K Current report, items 2.02, 7.01, and 9.01 Accession Number: 0001628280-24-009383 Act: 34 Size: 4 MB 网页链接
$ChromaDex(CDXC)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001628280-24-006724 Size: 5 KB 网页链接
$ChromaDex(CDXC)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001628280-24-006725 Size: 5 KB 网页链接
$ChromaDex(CDXC)$ 8-K Current report, items 1.01, 2.03, and 9.01 Accession Number: 0001628280-23-041428 Act: 34 Size: 274 KB 网页链接
$ChromaDex(CDXC)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001628280-23-040625 Size: 5 KB 网页链接
$ChromaDex(CDXC)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001628280-23-037809 Act: 34 Size: 7 MB 网页链接